PDF-An agency of the European Union

Organ Maturation TablesPossibly identifying maturation related adverse drug reactionsPresented by Janina KarresPaediatric Medicines 1 xMCIxD 10xMCIxD 10The RationaleBetter use of Eu. europaeu Website wwwemaeuropaeu European Medicines Agency 2014 Reproduction is authorised provided the s ource is acknowledged 26 May 2014 EMA1615302014 Inspections and Human Medicines Pharmacovigilance Division DRAFT etailed uid regarding the onit europaeu Website wwwemaeuropaeu European Medicines Agency 2013 Reproduction is authorised provided the source is acknowledged 22 May 2013 CHMP43704 Rev 1 Committee for Medicinal Products for Human Use CHMP Guideline on Similar Biological Medicinal europaeu Website wwwemaeuropaeu European Medicines Agenc y 2013 Reproduction is authorised provided the source is acknowledged 03 June May 2013 EMEACHMPBMWP428322005 Rev 1 Committee for Medicinal Products for Human Use CHMP Guideline on similar bio europaeu Website wwwemaeuropaeu European Medicines Agenc y 2013 Reproduction is authorised provided the source is acknowledged 03 June May 2013 EMEACHMPBMWP428322005 Rev 1 Committee for Medicinal Products for Human Use CHMP Guideline on similar bio europaeu Website wwwemaeuropaeu European Medicines Agency 2013 Reproduction is authorised provided the source is acknowledged 28 June 2013 EMA3857162013 Restrictions on use of codeine for pain relief in ch ildren CMDh endorses PRAC recommendation T emaeuropaeucontact European Medicines Agency 2014 Reproduction is authorised provided the source is acknowledged 21 July 2011 EMEACHMPEWP1922172009 Rev1 Corr Committee for Medicinal Products for Human Use CHMP Guideline on bioanalytical method vali europaeu Website wwwemaeuropaeu European Medicines Agency 2014 Reproduction is authorised provided the source is acknowledged 21 March 2014 EMA CHMPCVMPQWP4410712011 Rev2 Committee for Medicinal Products for Human Use CHMP Committee for Medicinal P The European regulatory system for medicines and the European Medicines Agency A consistent approach to medicines regulation across the European Union 2 The EU regulatory system for medicines The P. roposals 2017. reference framework. Single European Railway Area. Attractiveness and competitiveness of the European railway system . Leadership on the global market. key objectives. Innovation Programmes. european-semester.com the Texas A&M schedule. the philosophy, logic and design of the European Union by experience one of Europe’s leading political The schedule is contoured to the Texas A&M Up european-semester.com the Texas A&M schedule. the philosophy, logic and design of the European Union by experience one of Europe’s leading political The schedule is contoured to the Texas A&M Up EMA146s third public meeting 26 March 2021PCWP / HCPWP meeting 2 March 2021Nathalie BerePublic and Stakeholders Engagement DepartmentClassified as public by the European Medicines Agency ENGAGING THE Answers to Knowledge Check in the post-event surveySME and academia Clinical Trials Information System CTIS two-part training webinar day 2Classified as public by the European Medicines Agency Europe From Europe to the Euro. From Europe to the Euro. an outline. What is the EU. Before the Euro. The Euro. Time line. Map. United in diversity. Advantages/Benefits. Some definitions. Euro-zone. Advantages.